Company Filing History:
Years Active: 2017
Title: Innovations by Ozlem Demir: Enhancing P53 Activity
Introduction
Ozlem Demir, an accomplished inventor based in San Diego, CA, has made significant strides in the field of molecular biology. With a single patent to her name, she focuses her research on enhancing the activity of the p53 protein, which plays a crucial role in regulating the cell cycle and maintaining genomic stability.
Latest Patents
Ozlem's groundbreaking patent, titled "Small molecules to enhance P53 activity," presents a novel method for enhancing the activity of p53 mutant polypeptides. This method involves interacting with a compound at an open L1/S3 binding site of the p53 mutant polypeptide, leading to increased p53 activity in the presence of the identified compound. Her research emphasizes the identification of useful compounds through virtual drug screening databases, alongside methods to screen for compounds that bind to the p53 sites and their potential therapeutic applications.
Career Highlights
Ozlem Demir is currently affiliated with the University of California, where she contributes to the advancement of research in molecular biology. Her dedication to exploring the intricacies of p53 functionality highlights her commitment to innovation in the field. Through her work, she aims to bring forth novel therapies that may address critical health challenges related to p53 mutations.
Collaborations
Throughout her career, Ozlem has collaborated with distinguished colleagues such as Rommie E Amaro and Roberta Baronio. These collaborations foster an environment of shared knowledge and expertise, enhancing the research outcomes and potentially leading to impactful innovations in the field of drug development.
Conclusion
Ozlem Demir's innovative contributions to enhancing p53 activity demonstrate the potential of targeted molecular therapies in addressing genetic mutations. As she continues her work at the University of California, the scientific community eagerly anticipates the implications of her findings in the realm of molecular biology and cancer treatment.